Muscle involvement in Dent disease 2 |
| |
Authors: | Eujin Park Hyun Jin Choi Jiwon M. Lee Yo Han Ahn Hee Gyung Kang Yoo Mee Choi Se Jin Park Hee Yeon Cho Yong-Hoon Park Seung Joo Lee Il Soo Ha Hae Il Cheong |
| |
Affiliation: | 1. Department of Pediatrics, Seoul National University Children’s Hospital, 101 Daehak-Ro, Jongno-Gu, Seoul, 110-744, Korea 2. Research Coordination Center for Rare Diseases, Seoul National University Hospital, Seoul, Korea 3. Department of Pediatrics, Kyung Hee University School of Medicine, Seoul, Korea 4. Department of Pediatrics, Ajou University School of Medicine, Suwon, Korea 5. Department of Pediatrics, Samsung Medical Center, Seoul, Korea 6. Department of Pediatrics, Yeungnam University College of Medicine, Daegu, Korea 7. Department of Pediatrics, Ehwa University Mokdong Hospital, Seoul, Korea 8. Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea
|
| |
Abstract: | Background Dent disease, an X-linked recessive renal tubulopathy, is caused by mutations in either CLCN5 (Dent disease 1) or OCRL (Dent disease 2). OCRL mutations can also cause Lowe syndrome. In some cases it is difficult to differentiate Dent disease 1 and 2 on the basis of clinical features only without genetic tests. Several studies have shown differences in serum levels of muscle enzymes between these diseases. The aim of our study was to test the validity of these findings. Methods In total, 23 patients with Dent disease 1 (Group A), five patients with Dent disease 2 (Group B) and 19 patients with Lowe syndrome (Group C) were enrolled in our study. The serum levels of three muscle enzymes [creatine phosphokinase (CPK), lactate dehydrogenase (LDH), aspartate aminotransferase (AST)], were measured. The levels of a hepatic enzyme, alanine aminotransferase (ALT), were also measured as a control. Results One patient in Group B had muscle hypoplasia of both upper extremities. The serum levels of all three muscle enzymes assayed were higher in Group B or C patients than in Group A patients. Serum ALT levels were normal in all three groups of patients. Conclusions The serum levels of muscle enzymes in patients with Dent disease can be used as a biomarker to predict genotypes, even though the patients do not have clinical symptoms of muscle involvement. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|